allodynia glp-1 treatment Allodynia: Unusual Complication of Medications Advances in GLP-1 receptor agonists
Description
clinically tested
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed
GLP-1 use is rising (even in comp)
Keeps: 4 days in fridge
Thus, oral administration of a peptide therapeutic represents a significant advance in medicine, but is challenged by gastrointestinal instability and ineffective uptake into the circulation
